Cite
HARVARD Citation
Aaltonen, K. et al. (2014). THU0178 Rates of Serious Infections and Malignancies among Rheumatoid Arthritis Patients Receiving Either Tnf-Blocker or Rituximab Therapy in Finland. Annals of the rheumatic diseases. p. 242. [Online].